TRAPANI, DARIO
TRAPANI, DARIO
Dipartimento di Oncologia ed Emato-Oncologia
Neoadjuvant therapy in hormone Receptor-Positive/HER2-Negative breast cancer
2024 L. Cantini, D. Trapani, L. Guidi, L. Boscolo Bielo, R. Scafetta, M. Koziej, L. Vidal, K.S. Saini, G. Curigliano
Cardiotoxicity of Agents Used in Patients With Breast Cancer
2024 P. Zagami, D. Trapani, E. Nicolò, C. Corti, C. Valenza, C. Criscitiello, G. Curigliano, L.A. Carey
Grading of recommendations, assessment, development and evaluations concept 7: issues and insights linking guideline recommendations to trustworthy essential medicine lists
2024 T. Piggott, L. Moja, K. Jenei, T. Kredo, N. Skoetz, R. Banzi, D. Trapani, T. Leong, M. Mccaul, J.N. Lavis, E.A. Akl, F. Nonino, A. Iorio, J. Laurson-Doube, B.D. Huttner, H.J. Schünemann
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
2024 S. Loibl, F. André, T. Bachelot, C.H. Barrios, J. Bergh, H.J. Burstein, M.J. Cardoso, L.A. Carey, S. Dawood, L. Del Mastro, C. Denkert, E.M. Fallenberg, P.A. Francis, H. Gamal-Eldin, K. Gelmon, C.E. Geyer, M. Gnant, V. Guarneri, S. Gupta, S.B. Kim, D. Krug, M. Kater, I. Meattini, M. Morrow, W. Janni, S. Paluch-Shimon, A. Partridge, P. Poortmans, L. Pusztai, M.M. Regan, J. Sparano, T. Spanic, S. Swain, S. Tjulandin, M. Toi, D. Trapani, A. Tutt, B. Xu, G. Curigliano, N. Harbeck
Biomarkers for antibody-drug conjugates in solid tumors
2024 J. Katrini, L. Boldrini, C. Santoro, C. Valenza, D. Trapani, G. Curigliano
Tackling the implementation gap for the uptake of NGS and advanced molecular diagnostics into healthcare systems
2024 D. Horgan, M. Van den Bulcke, U. Malapelle, G. Troncone, N. Normanno, E.D. Capoluongo, A. Prelaj, C. Rizzari, D. Trapani, J. Singh, M. Kozaric, J. Longshore, M. Ottaviano, S. Boccia, G. Pravettoni, I. Cattaneo, N. Malats, R. Buettner, K. Lekadir, F. de Lorenzo, P. Hofman, R. De Maria
Radiation therapy, tissue radiosensitization, and potential synergism in the era of novel antibody-drug conjugates
2024 S. Natangelo, D. Trapani, C. Koukoutzeli, L. Boscolo Bielo, G. Marvaso, B.A. Jereczek-Fossa, G. Curigliano
Primary malignant phyllodes tumors of the breast: A retrospective analysis from a referral center
2024 C. Valenza, T.M. De Pas, A. Gaeta, G. Castellano, C. Santoro, A. Corona, G. Chiappini, G. Vivanet, D. Trapani, S. Coppola, F. Conforti, D. Mattar, S. Gandini, P. Veronesi, E. Pennacchioli, G. Curigliano
A conceptual framework for cautious escalation of anticancer treatment: How to optimize overall benefit and obviate the need for de-escalation trials
2024 I. Pourmir, H.K. Van Halteren, R. Elaidi, D. Trapani, F. Strasser, G. Vreugdenhil, M. Clarke
WHO model list of essential in vitro diagnostics: strengthening diagnostics capacity to transform health care for all
2024 D. Trapani, P.J. Garcia, L. Schroeder, R. Abdul-Ghani, A. Hansali, P.N. Offutalu, W. Sewell, S. Shakoor, L. Yunfeng, N. Hashimoto, F.G. Moussy, A. Aceves Capri, K. Fleming
Standardized molecular pathology workflow for ctDNA-based ESR1 testing in HR+/HER2- metastatic breast cancer
2024 E. Guerini-Rocco, K. Venetis, G. Cursano, E. Mane, C. Frascarelli, F. Pepe, M. Negrelli, E. Olmeda, D. Vacirca, A. Ranghiero, D. Trapani, C. Criscitiello, G. Curigliano, C. Rolfo, U. Malapelle, N. Fusco
Establishing a Lancet Oncology Commission on the humanitarian crisis of cancer
2023 G. Rodin, M. Skelton, N. Bhoo-Pathy, O. Dewachi, M. Li, D. Trapani, E. Smyth, M. Banegas, N. Salins, K. Unger-Saldaña, C. Zimmermann, R. Sullivan
Impact of Prior Authorization on Patient Access to Cancer Care
2023 D. Trapani, L. Kraemer, H.S. Rugo, N.U. Lin
Screening Programs for Breast Cancer: Toward Individualized, Risk-Adapted Strategies of Early Detection
2023 D. Trapani, J. Sandoval, P.T. Aliaga, L. Ascione, P.P. Maria Berton Giachetti, G. Curigliano, O. Ginsburg
Next-Generation Sequencing for Advanced Breast Cancer: What the Way to Go?
2023 D. Trapani, E. Crimini, J. Sandoval, G. Curigliano
Durable responses in patients with HER2+ breast cancer and leptomeningeal metastases treated with trastuzumab deruxtecan
2023 L. Alder, D. Trapani, C. Bradbury, A.E.D. Van Swearingen, S.M. Tolaney, M. Khasraw, C.K. Anders, C.D. Lascola, L. Hsu, N.U. Lin, S. Sammons
Platinum-based chemotherapy and PARP inhibitors for patients with a germline BRCA pathogenic variant and advanced breast cancer (LATER-BC): retrospective multicentric analysis of post-progression treatments
2023 C. Valenza, D. Trapani, S. Gandini, C. Sposetti, L. Boscolo Bielo, A. Marra, T. Giarratano, D. Favero, L. Cortesi, L. Moscetti, M. Pistelli, R. Berardi, A. Zambelli, M. Lambertini, L. Del Mastro, V. Guarneri, C. Vernieri, G. Curigliano
Cancer in Transgender and Gender-Diverse Persons: A Review
2023 A.G. Leone, D. Trapani, M.B. Schabath, J.D. Safer, N.F.N. Scout, M. Lambertini, R. Berardi, S. Marsoni, F. Perrone, S. Cinieri, R. Miceli, F. Morano, F. Pietrantonio
Evolving treatment landscape of immunotherapy in breast cancer: current issues and future perspectives
2023 C. Valenza, G. Rizzo, M.I. Passalacqua, L. Boldrini, C. Corti, D. Trapani, G. Curigliano
ESMO-Magnitude of Clinical Benefit Scale for haematological malignancies (ESMO-MCBS:H) version 1.0
2023 B. Kiesewetter, U. Dafni, E.G.E. de Vries, J. Barriuso, G. Curigliano, V. González-Calle, M. Galotti, B. Gyawali, B.J.P. Huntly, U. Jäger, N.J. Latino, L. Malcovati, S.F. Oosting, G. Ossenkoppele, M. Piccart, M. Raderer, L. Scarfò, D. Trapani, C.C. Zielinski, R. Wester, P. Zygoura, E. Macintyre, N.I. Cherny